Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Employer
- SINGAPORE INSTITUTE OF TECHNOLOGY (SIT)
- University of Oslo
- INESC TEC
- Instituto de Investigação e Inovação em Saúde da Universidade do Porto (i3S)
- MACQUARIE UNIVERSITY - SYDNEY AUSTRALIA
- Nanyang Technological University
- Nature Careers
- Princeton University
- UNIVERSITY OF THE SUNSHINE COAST - UNISC
- UiT The Arctic University of Norway
- Universidade de Aveiro
- University of Agder
- University of Agder (UiA)
- University of Colorado
- University of Michigan
- University of Michigan - Ann Arbor
- University of Oxford
- Université Gustave Eiffel
- 8 more »
- « less
-
Field
-
MACQUARIE UNIVERSITY - SYDNEY AUSTRALIA | North Ryde, New South Wales | Australia | about 1 month ago
rather than having a researcher building one strain at a time manually, the same researcher could build hundreds or thousands of strains in parallel using our robotic platforms. The Australian Genome
-
Programme? Not funded by a EU programme Reference Number AE2025-0575 Is the Job related to staff position within a Research Infrastructure? No Offer Description Portuguese version: https
-
strengthen parallel language practices and the conditions for using Norwegian professional language across educational and workplace contexts? The position advertised at UiA will be linked to the use
-
coordinate parallel trials with in-country teams across partner nations; Oversee seaweed sample collection and processing with in-country teams, and contribute directly to field sampling where required
-
project partners. In parallel, support will be provided for the implementation and operationalization of the financial, economic, structural and risk performance indicators developed within the NEXUS
-
compliance with Work, Safety and Health Regulations. Work independently, as well as within a team, to ensure proper operation and maintenance of equipment. The employee is to communicate with any relevant
-
of structure-function quantifications. We also perform CRISPRa high throughput screening and massively parallel reporter assays (MPRAs) in iPSC-CMs. A current major focus of the lab is implementation of MPRAs
-
Instituto de Investigação e Inovação em Saúde da Universidade do Porto (i3S) | Portugal | 3 months ago
chemotherapy and targeted RNA delivery”, ref. COMPETE2030-FEDER-00683900, Operation No. 15733, funded by COMPETE2030 and national funds (FCT) under Notice no. MPr-2023-12. Host Institution: i3S - Instituto de
-
bundle platform we developed to increase rigor of structure-function quantifications. We also perform CRISPRa high throughput screening and massively parallel reporter assays (MPRAs) in iPSC-CMs. A current
-
model is employed to forecast renewable energy availability, providing crucial insights for the design optimization process. The ML-assisted operation tackles the dynamic optimization of parallel energy